Denali Therapeutics IncNASDAQ:DNLI
- LAST PRICE29.1300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots29.0000/ 1
- Ask / Lots32.8200/ 3
- Open / Previous Close--- / 29.1300
- Day Range---
- 52 Week Range
- Volume50
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DNLI |
|---|---|---|
| 09:32 ET | 7819 | 28.96 |
| 09:36 ET | 815 | 28.840461 |
| 09:38 ET | 1100 | 28.995 |
| 09:39 ET | 1210 | 29.16 |
| 09:41 ET | 4708 | 29.17 |
| 09:43 ET | 6300 | 29.2 |
| 09:45 ET | 5560 | 29.17 |
| 09:48 ET | 700 | 29.245 |
| 09:50 ET | 800 | 29.31 |
| 09:52 ET | 150 | 29.26 |
| 09:54 ET | 2227 | 29.29 |
| 09:56 ET | 100 | 29.3 |
| 09:57 ET | 300 | 29.285 |
| 09:59 ET | 2001 | 29.085 |
| 10:03 ET | 200 | 29.11 |
| 10:06 ET | 1531 | 29.15 |
| 10:08 ET | 1822 | 29.235 |
| 10:10 ET | 300 | 29.24 |
| 10:12 ET | 200 | 29.24 |
| 10:14 ET | 777 | 29.19 |
| 10:15 ET | 800 | 29.14 |
| 10:17 ET | 333 | 29.09 |
| 10:19 ET | 105 | 29.115 |
| 10:21 ET | 500 | 29.02 |
| 10:24 ET | 487 | 29.03 |
| 10:26 ET | 1300 | 29.025 |
| 10:28 ET | 1591 | 29.045 |
| 10:30 ET | 1256 | 28.905 |
| 10:32 ET | 788 | 28.893 |
| 10:33 ET | 2009 | 28.975 |
| 10:35 ET | 200 | 28.995 |
| 10:37 ET | 200 | 29.03 |
| 10:39 ET | 224 | 29.01 |
| 10:42 ET | 590 | 29.035 |
| 10:44 ET | 300 | 29.02 |
| 10:46 ET | 100 | 29.02 |
| 10:48 ET | 200 | 29.06 |
| 10:50 ET | 200 | 29.04 |
| 10:51 ET | 300 | 28.995 |
| 10:53 ET | 550 | 28.98 |
| 10:55 ET | 200 | 29.015 |
| 10:57 ET | 813 | 29 |
| 11:00 ET | 700 | 29.01 |
| 11:02 ET | 100 | 29.02 |
| 11:04 ET | 300 | 29.05 |
| 11:06 ET | 400 | 29.055 |
| 11:08 ET | 1068 | 29.095 |
| 11:09 ET | 500 | 29.11 |
| 11:11 ET | 200 | 29.09 |
| 11:13 ET | 400 | 29.085 |
| 11:15 ET | 100 | 29.12 |
| 11:18 ET | 100 | 29.21 |
| 11:20 ET | 123 | 29.2072 |
| 11:22 ET | 473 | 29.2061 |
| 11:24 ET | 300 | 29.215 |
| 11:26 ET | 1053 | 29.225 |
| 11:27 ET | 450 | 29.18 |
| 11:29 ET | 200 | 29.165 |
| 11:31 ET | 200 | 29.11 |
| 11:33 ET | 2005 | 29.0861 |
| 11:36 ET | 1013 | 29.02 |
| 11:38 ET | 100 | 29.04 |
| 11:40 ET | 931 | 29.04 |
| 11:42 ET | 4248 | 29.01 |
| 11:44 ET | 306 | 28.98 |
| 11:45 ET | 500 | 29.04 |
| 11:47 ET | 873 | 29 |
| 11:49 ET | 125 | 29.01 |
| 11:51 ET | 2087 | 28.98 |
| 11:54 ET | 1374 | 28.97 |
| 11:56 ET | 2160 | 28.95 |
| 11:58 ET | 800 | 28.98 |
| 12:00 ET | 575 | 28.98 |
| 12:03 ET | 1300 | 28.93 |
| 12:05 ET | 450 | 28.945 |
| 12:07 ET | 1600 | 28.93 |
| 12:09 ET | 457 | 28.915 |
| 12:12 ET | 1600 | 28.94 |
| 12:14 ET | 1200 | 28.93 |
| 12:16 ET | 750 | 28.94 |
| 12:18 ET | 400 | 28.95 |
| 12:20 ET | 515 | 28.98 |
| 12:21 ET | 322 | 28.95 |
| 12:23 ET | 2750 | 29.02 |
| 12:25 ET | 1100 | 29.0204 |
| 12:27 ET | 200 | 29.03 |
| 12:32 ET | 600 | 29.05 |
| 12:34 ET | 100 | 29.07 |
| 12:36 ET | 100 | 29.04 |
| 12:39 ET | 329 | 29.025 |
| 12:43 ET | 100 | 29 |
| 12:45 ET | 601 | 29.02 |
| 12:48 ET | 900 | 29.01 |
| 12:52 ET | 500 | 29.0175 |
| 12:54 ET | 300 | 29 |
| 12:56 ET | 200 | 28.97 |
| 12:57 ET | 1075 | 28.96 |
| 12:59 ET | 500 | 28.99 |
| 01:01 ET | 100 | 29 |
| 01:06 ET | 100 | 28.93 |
| 01:08 ET | 500 | 28.94 |
| 01:10 ET | 650 | 28.96 |
| 01:12 ET | 1050 | 28.97 |
| 01:14 ET | 1626 | 28.93 |
| 01:15 ET | 381 | 28.91 |
| 01:19 ET | 100 | 28.895 |
| 01:21 ET | 225 | 28.895 |
| 01:24 ET | 4131 | 28.89 |
| 01:26 ET | 1000 | 28.85 |
| 01:28 ET | 1028 | 28.83 |
| 01:30 ET | 400 | 28.79 |
| 01:32 ET | 100 | 28.77 |
| 01:33 ET | 500 | 28.73 |
| 01:35 ET | 700 | 28.735 |
| 01:37 ET | 100 | 28.735 |
| 01:39 ET | 400 | 28.735 |
| 01:42 ET | 1212 | 28.725 |
| 01:44 ET | 778 | 28.74 |
| 01:46 ET | 300 | 28.74 |
| 01:48 ET | 550 | 28.74 |
| 01:50 ET | 500 | 28.73 |
| 01:51 ET | 2059 | 28.73 |
| 01:53 ET | 1700 | 28.745 |
| 01:55 ET | 1100 | 28.77 |
| 01:57 ET | 1423 | 28.76 |
| 02:00 ET | 250 | 28.75 |
| 02:02 ET | 1067 | 28.813 |
| 02:04 ET | 400 | 28.77 |
| 02:08 ET | 293 | 28.7 |
| 02:09 ET | 1865 | 28.73 |
| 02:11 ET | 100 | 28.745 |
| 02:13 ET | 4673 | 28.65 |
| 02:15 ET | 2073 | 28.61 |
| 02:18 ET | 200 | 28.65 |
| 02:20 ET | 100 | 28.63 |
| 02:22 ET | 945 | 28.595 |
| 02:24 ET | 300 | 28.54 |
| 02:26 ET | 1010 | 28.5 |
| 02:27 ET | 723 | 28.56 |
| 02:29 ET | 1400 | 28.57 |
| 02:33 ET | 500 | 28.5653 |
| 02:36 ET | 720 | 28.63 |
| 02:38 ET | 400 | 28.68 |
| 02:40 ET | 1236 | 28.75 |
| 02:42 ET | 600 | 28.79 |
| 02:44 ET | 434 | 28.785 |
| 02:45 ET | 500 | 28.83 |
| 02:47 ET | 2603 | 28.86 |
| 02:49 ET | 2829 | 28.88 |
| 02:51 ET | 4144 | 28.805 |
| 02:54 ET | 800 | 28.81 |
| 02:56 ET | 1200 | 28.83 |
| 02:58 ET | 250 | 28.82 |
| 03:00 ET | 650 | 28.76 |
| 03:02 ET | 2247 | 28.68 |
| 03:03 ET | 600 | 28.71 |
| 03:05 ET | 400 | 28.72 |
| 03:07 ET | 1400 | 28.75 |
| 03:09 ET | 9631 | 28.85 |
| 03:12 ET | 2529 | 28.88 |
| 03:14 ET | 1150 | 28.78 |
| 03:16 ET | 100 | 28.8 |
| 03:18 ET | 600 | 28.805 |
| 03:20 ET | 700 | 28.86 |
| 03:21 ET | 100 | 28.822 |
| 03:23 ET | 506 | 28.84 |
| 03:27 ET | 450 | 28.86 |
| 03:30 ET | 1553 | 28.83 |
| 03:32 ET | 14775 | 28.8 |
| 03:34 ET | 1300 | 28.79 |
| 03:36 ET | 982 | 28.79 |
| 03:38 ET | 100 | 28.79 |
| 03:39 ET | 1000 | 28.82 |
| 03:41 ET | 3999 | 28.795 |
| 03:43 ET | 600 | 28.8 |
| 03:45 ET | 1200 | 28.83 |
| 03:48 ET | 1493 | 28.87 |
| 03:50 ET | 4997 | 28.89 |
| 03:52 ET | 7740 | 28.96 |
| 03:54 ET | 7810 | 29.06 |
| 03:56 ET | 6007 | 29.02 |
| 03:57 ET | 8558 | 29.08 |
| 03:59 ET | 194239 | 29.13 |
Sep 9, 2024
DJ Denali Therapeutics Price Target Maintained With a $35.00/Share by Cantor Fitzgerald, from 11:46AM ET on Monday Sep 09, 2024 by Dow Jones
11:46AM ET on Monday Sep 09, 2024 by Dow Jones
Sep 4, 2024
DJ Denali Therapeutics Price Target Maintained With a $90.00/Share by HC Wainwright & Co., from 7:47AM ET on Wednesday Sep 04, 2024 by Dow Jones
7:47AM ET on Wednesday Sep 04, 2024 by Dow JonesDJ Denali Therapeutics Is Maintained at Buy by B of A Securities, from 7:47AM ET on Wednesday Sep 04, 2024 by Dow Jones
7:47AM ET on Wednesday Sep 04, 2024 by Dow Jones
Sep 3, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Denali Therapeutics Inc | 4.2B | -10.2x | --- |
CRISPR Therapeutics AG | 4.0B | -14.7x | --- |
Axsome Therapeutics Inc | 4.3B | -13.8x | --- |
ADMA Biologics Inc | 4.7B | 142.2x | --- |
Apellis Pharmaceuticals Inc | 3.5B | -10.5x | --- |
TG Therapeutics Inc | 3.6B | 39.0x | --- |
Company Information
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Contact Information
- Headquarters
- 161 Oyster Point BlvdSOUTH SAN FRANCISCO, CA, United States 94080-1910
- Phone
- 650-866-8548
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Vicki Sato
- President, Chief Executive Officer, Director
- Ryan Watts
- Chief Financial Officer, Chief Operating Officer, Company Secretary
- Alexander Schuth
- Chief Medical Officer
- Carole Ho
- Director
- Steven Krognes
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
|---|---|
Revenue (TTM) | $1.3M |
Shares Outstanding | 143.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.38 |
EPS | $-2.85 |
Book Value | $7.45 |
P/E Ratio | -10.2x |
Price/Sales (TTM) | 3,291.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -37,938.04% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
